{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:17:22Z","timestamp":1791087442620,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Biotechnology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.copbio.2012.03.007","type":"journal-article","created":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T20:02:12Z","timestamp":1333569732000},"page":"900-907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Recombinant live vaccine candidates against tuberculosis"],"prefix":"10.1016","volume":"23","author":[{"given":"Stefan HE","family":"Kaufmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gengenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.copbio.2012.03.007_bib0005","series-title":"La vaccination pr\u00e9ventive contre la tuberculose par le \u201cBCG\u201d","author":"Calmette","year":"1927"},{"key":"10.1016\/j.copbio.2012.03.007_bib0010","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/513642","article-title":"Disseminated bacille Calmette-Guerin disease after vaccination: case report and review","volume":"24","author":"Talbot","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.copbio.2012.03.007_bib0015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(10)60393-5","article-title":"New vaccines for tuberculosis","volume":"375","author":"Kaufmann","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.copbio.2012.03.007_bib0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(10)62173-3","article-title":"Tuberculosis","volume":"378","author":"Lawn","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.copbio.2012.03.007_bib0025","unstructured":"WHO: Global Tuberculosis Control 2011. Geneva, World Health Organization; 2011."},{"key":"10.1016\/j.copbio.2012.03.007_bib0030_1","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(10)60410-2","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis","volume":"375","author":"Gandhi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.copbio.2012.03.007_bib0035","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/cid\/cir889","article-title":"Totally drug-resistant tuberculosis in India","volume":"54","author":"Udwadia","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.copbio.2012.03.007_bib0040","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.0700869104","article-title":"Genome plasticity of BCG and impact on vaccine efficacy","volume":"104","author":"Brosch","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.copbio.2012.03.007_bib0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/IAI.74.1.88-98.2006","article-title":"Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence","volume":"74","author":"Brodin","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.copbio.2012.03.007_bib0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mib.2008.11.003","article-title":"ESX\/type VII secretion systems and their role in host-pathogen interaction","volume":"12","author":"Simeone","year":"2009","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.copbio.2012.03.007_bib0055","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.4049\/jimmunol.174.6.3570","article-title":"Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system","volume":"174","author":"Majlessi","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.copbio.2012.03.007_bib0060","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","article-title":"Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis","volume":"9","author":"Pym","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.copbio.2012.03.007_bib0065","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.vaccine.2008.10.058","article-title":"Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis","volume":"27","author":"Horwitz","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.copbio.2012.03.007_bib0070","doi-asserted-by":"crossref","first-page":"9308","DOI":"10.1016\/j.vaccine.2011.10.019","article-title":"BCG sub-strains induce variable protection against virulent pulmonary Mycobacterium tuberculosis infection, with the capacity to drive Th2 immunity","volume":"29","author":"Keyser","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.copbio.2012.03.007_bib0075","series-title":"Protective Effect of BCG in Experimental Tuberculosis","author":"Smith","year":"1985"},{"key":"10.1016\/j.copbio.2012.03.007_bib0080","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.copbio.2012.03.007_bib0085","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.cell.2007.05.059","article-title":"M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells","volume":"129","author":"van der Wel","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.copbio.2012.03.007_bib0090_1","doi-asserted-by":"crossref","unstructured":"Gengenbacher M, Kaufmann SHE: Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol Rev 2012, http:\/\/dx.doi.org\/10.1111\/j.1574-6976.2012.00331.x.","DOI":"10.1111\/j.1574-6976.2012.00331.x"},{"key":"10.1016\/j.copbio.2012.03.007_bib0095_1","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.vaccine.2009.12.083","article-title":"The second Geneva Consensus: recommendations for novel live TB vaccines","volume":"28","author":"Walker","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.copbio.2012.03.007_bib0100_1","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.811","article-title":"Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection","volume":"43","author":"Ford","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.copbio.2012.03.007_bib0105","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1473-3099(11)70146-3","article-title":"Fact and fiction in tuberculosis vaccine research: 10 years later","volume":"11","author":"Kaufmann","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.copbio.2012.03.007_bib0110","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1128\/iai.55.11.2822-2829.1987","article-title":"In vitro model of penetration and intracellular growth of Listeria monocytogenes in the human enterocyte-like cell line Caco-2","volume":"55","author":"Gaillard","year":"1987","journal-title":"Infect Immun"},{"key":"10.1016\/j.copbio.2012.03.007_bib0115","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1128\/iai.55.7.1641-1646.1987","article-title":"Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes","volume":"55","author":"Geoffroy","year":"1987","journal-title":"Infect Immun"},{"key":"10.1016\/j.copbio.2012.03.007_bib0120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1742-4658.2011.08405.x","article-title":"pH dependence of listeriolysin O aggregation and pore-forming ability","volume":"279","author":"Bavdek","year":"2012","journal-title":"FEBS J"},{"key":"10.1016\/j.copbio.2012.03.007_bib0125","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.290.5493.992","article-title":"A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity","volume":"290","author":"Decatur","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.copbio.2012.03.007_bib0130","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1462-5822.2005.00631.x","article-title":"Phosphorylation, ubiquitination and degradation of listeriolysin O in mammalian cells: role of the PEST-like sequence","volume":"8","author":"Schnupf","year":"2006","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.copbio.2012.03.007_bib0135","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1073\/pnas.95.9.5299","article-title":"Mycobacterium bovis bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes","volume":"95","author":"Hess","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.copbio.2012.03.007_bib0140","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Gu\u00e9rin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.copbio.2012.03.007_bib0145","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/infdis\/jir592","article-title":"Recombinant BCG \u0394ureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses","volume":"204","author":"Desel","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.copbio.2012.03.007_bib0150","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","article-title":"Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model","volume":"97","author":"Horwitz","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.copbio.2012.03.007_bib0155","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/IAI.71.4.1672-1679.2003","article-title":"A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis","volume":"71","author":"Horwitz","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.copbio.2012.03.007_bib0160","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1086\/592450","article-title":"A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers","volume":"198","author":"Hoft","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.copbio.2012.03.007_bib0165","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1128\/IAI.00434-08","article-title":"A replication-limited recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG","volume":"76","author":"Tullius","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.copbio.2012.03.007_bib0170","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.334.6062.1488","article-title":"Infectious disease. Taking a new shot at a TB vaccine","volume":"334","author":"Kupferschmidt","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.copbio.2012.03.007_bib0175","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1016\/j.vaccine.2009.05.048","article-title":"Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.copbio.2012.03.007_bib0180","doi-asserted-by":"crossref","first-page":"e5590","DOI":"10.1371\/journal.pone.0005590","article-title":"Identification of T-cell antigens specific for latent Mycobacterium tuberculosis infection","volume":"4","author":"Schuck","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.copbio.2012.03.007_bib0185","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1128\/IAI.73.10.6199-6209.2005","article-title":"Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins","volume":"73","author":"Tweten","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.copbio.2012.03.007_bib0190","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2958.2001.02500.x","article-title":"An essential role for phoP in Mycobacterium tuberculosis virulence","volume":"41","author":"Perez","year":"2001","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.copbio.2012.03.007_bib0195","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1371\/journal.ppat.0040033","article-title":"Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP","volume":"4","author":"Frigui","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.copbio.2012.03.007_bib0200","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2006.03.017","article-title":"The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs","volume":"24","author":"Martin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.copbio.2012.03.007_bib0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2249.2005.02832.x","article-title":"Immunogenicity and protective efficacy of the Mycobacterium tuberculosis fadD26 mutant","volume":"141","author":"Infante","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.copbio.2012.03.007_bib0210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.micinf.2008.10.013","article-title":"Intracellular replication of attenuated Mycobacterium tuberculosis phoP mutant in the absence of host cell cytotoxicity","volume":"11","author":"Ferrer","year":"2009","journal-title":"Microbes Infect"},{"key":"10.1016\/j.copbio.2012.03.007_bib0215","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.vaccine.2009.02.060","article-title":"Extended safety studies of the attenuated live tuberculosis vaccine SO2 based on phoP mutant","volume":"27","author":"Cardona","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.copbio.2012.03.007_bib0220","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.chom.2008.03.003","article-title":"Mycobacterium tuberculosis prevents inflammasome activation","volume":"3","author":"Master","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.copbio.2012.03.007_bib0225_1","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/CVI.00015-11","article-title":"Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens","volume":"18","author":"Johansen","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.copbio.2012.03.007_bib0230","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1016\/j.vaccine.2006.05.097","article-title":"Mycobacterium tuberculosis \u0394RD1 \u0394panCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis","volume":"24","author":"Sambandamurthy","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.copbio.2012.03.007_bib0235","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.micinf.2005.04.001","article-title":"Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis","volume":"7","author":"Sambandamurthy","year":"2005","journal-title":"Microbes Infect"},{"key":"10.1016\/j.copbio.2012.03.007_bib0240","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/IAI.72.5.3031-3037.2004","article-title":"Protection elicited by a double leucine and pantothenate auxotroph of Mycobacterium tuberculosis in guinea pigs","volume":"72","author":"Sampson","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.copbio.2012.03.007_bib0245","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1365-2958.2010.07381.x","article-title":"Vitamin B6 biosynthesis is essential for survival and virulence of Mycobacterium tuberculosis","volume":"78","author":"Dick","year":"2010","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.copbio.2012.03.007_bib0250","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2001-2-10-research0044","article-title":"The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria","volume":"2","author":"Gey van Pittius","year":"2001","journal-title":"Genome Biol"},{"key":"10.1016\/j.copbio.2012.03.007_bib0255","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1101\/gr.075069.107","article-title":"Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis","volume":"18","author":"Stinear","year":"2008","journal-title":"Genome Res"},{"key":"10.1016\/j.copbio.2012.03.007_bib0260","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nm.2420","article-title":"A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis","volume":"17","author":"Sweeney","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.copbio.2012.03.007_bib0265","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00109-007-0157-6","article-title":"Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis","volume":"85","author":"Jacobsen","year":"2007","journal-title":"J Mol Med"},{"key":"10.1016\/j.copbio.2012.03.007_bib0270","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.copbio.2012.03.007_bib0275","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/S0140-6736(10)60409-6","article-title":"The HIV-associated tuberculosis epidemic\u2014when will we act?","volume":"375","author":"Harries","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.copbio.2012.03.007_bib0280","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/infdis\/172.3.698","article-title":"Recombinant bacille Calmette-Guerin priming against measles","volume":"172","author":"Fennelly","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.copbio.2012.03.007_bib0285","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.vaccine.2005.11.029","article-title":"Immunisation with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L1 gene provides protection from CRPV challenge","volume":"24","author":"Govan","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.copbio.2012.03.007_bib0290","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1084\/jem.180.6.2277","article-title":"Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guerin vaccines expressing pneumococcal surface protein A","volume":"180","author":"Langermann","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.copbio.2012.03.007_bib0295","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0264-410X(98)00276-X","article-title":"Safety and immunogenicity of recombinant Bacille Calmette-Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine","volume":"17","author":"Edelman","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.copbio.2012.03.007_bib0300","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1084\/jem.178.1.197","article-title":"Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine","volume":"178","author":"Stover","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.copbio.2012.03.007_bib0305_1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2174\/157016210791208686","article-title":"Recombinant Mycobacterium bovis BCG as an HIV vaccine vector","volume":"8","author":"Chapman","year":"2010","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.copbio.2012.03.007_bib0310","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1084\/jem.188.5.845","article-title":"Recombinant Mycobacterium bovis bacillus Calmette-Guerin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies","volume":"188","author":"Matsumoto","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.copbio.2012.03.007_bib0315","article-title":"A recombinant Bacille Calmette-Guerin construct expressing the Plasmodium falciparum circumsporozoite protein enhances dendritic cell activation and primes for circumsporozoite-specific memory cells in BALB\/c mice","author":"Arama","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.copbio.2012.03.007_bib0320","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/ni1105-1063","article-title":"From bacteriology to immunology: the dualism of specificity","volume":"6","author":"Kaufmann","year":"2005","journal-title":"Nat Immunol"}],"container-title":["Current Opinion in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166912000547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166912000547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T08:45:18Z","timestamp":1760690718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958166912000547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0958166912000547"],"URL":"https:\/\/doi.org\/10.1016\/j.copbio.2012.03.007","relation":{},"ISSN":["0958-1669"],"issn-type":[{"value":"0958-1669","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant live vaccine candidates against tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.copbio.2012.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}